IDO1 and pancreatic neoplasm: We then examined if inhibition of IDO by PEG2k-Fmoc-NLG(L) led to enhanced T-cell proliferation in an in vitro lymphocyte and Panc02 (a murine pancreatic cancer cell line) coculture experiment.